title: Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.
abstract: BACKGROUND
  Radiation therapy is an important cancer treatment modality in both adjuvant and definitive setting, however, the use of radiation therapy for elective treatment of regional lymph nodes is controversial for pancreatic cancer. No consensus on proper selection and delineation of subclinical lymph nodal areas in adjuvant or definitive radiation therapy has been suggested either conclusively or proposed for further investigation. This analysis aims to study the pattern of lymph node metastasis through a pooled analysis of published results after radical tumor and lymph nodal resection with histological study in pancreatic cancer.
  
  
  METHODS
  Literature search using electronic databases including MEDLINE, EMBASE, and CANCERLIT from January 1970 to June 2009 was performed, supplemented by review of references. Eighteen original researches and a total of 5954 pancreatic cancer patients underwent radical surgical resection were included in this analysis. The probability of metastasis in regional lymph nodal stations (using Japan Pancreas Society [JPS] Classification) was calculated and analyzed based on the location and other characteristics of the primary disease.
  
  
  RESULTS
  Commonly involved nodal regions in patients with pancreatic head tumor include lymph nodes around the common hepatic artery (Group 8, 9.79%), posterior pancreaticoduodenal lymph nodes (Group 13, 32.31%), lymph nodes around the superior mesenteric artery (Group 14, 15.85%), paraaortic lymph nodes (Group 16, 10.92%), and anterior pancreaticoduodenal lymph nodes (Group 17, 19.78%); The probability of metastasis in other lymph nodal regions were <9%.Commonly involved nodal regions in patients with pancreatic body/tail tumor include lymph nodes around the common hepatic artery (Group 8, 15.07%), lymph nodes around the celiac trunk (Group 9, 9.59%), lymph nodes along the splenic artery (Group 11, 35.62%), lymph nodes around the superior mesenteric artery (Group 14, 9.59%), paraaortic lymph nodes (Group 16, 16.44%), and inferior body lymph nodes (Group 18, 24.66%). The probability of metastasis in other lymph nodal regions were <9%.
  
  
  CONCLUSIONS
  Pancreatic cancer has a high propensity of regional lymphatic metastases; however, clear patterns including the site and probability of metastasis can be identified and used as a guide of treatment in patients with resectable pancreatic cancer. Further clinical investigation is needed to study the efficacy of elective treatment to CTV defined based on these patterns using high-dose conformal or intensity-modulated radiation therapy.
authors.affiliation: Department of Radiation Oncology, Fudan University Shanghai Cancer Center Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
authors.forename: Wenjie
authors.initials: W
authors.lastname: Sun
authors.forename: Cheng N
authors.initials: CN
authors.lastname: Leong
authors.forename: Zhen
authors.initials: Z
authors.lastname: Zhang
authors.forename: Jiade J
authors.initials: JJ
authors.lastname: Lu
mesh_terms: D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000528:radiation effects*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D011379:Prognosis; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted
references.citation: Radiother Oncol. 2003 Jul;68(1):69-74
references.pmid: 12885454
references.citation: Cancer Radiother. 2009 Oct;13(6-7):594-9
references.pmid: 19766523
references.citation: Cancer. 1994 Feb 15;73(4):1155-62
references.pmid: 8313317
references.citation: Surgery. 2005 Oct;138(4):618-28; discussion 628-30
references.pmid: 16269290
references.citation: Ann Surg. 1988 Aug;208(2):215-20
references.pmid: 2840866
references.citation: Eur J Surg Oncol. 2007 Sep;33(7):887-91
references.pmid: 17433604
references.citation: Br J Surg. 1997 Aug;84(8):1090-2
references.pmid: 9278647
references.citation: Cancer. 1996 Dec 15;78(12):2485-91
references.pmid: 8952555
references.citation: Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):618-25
references.pmid: 19683403
references.citation: Cancer. 1978 Mar;41(3):880-7
references.pmid: 638975
references.citation: Cancer. 1981 Oct 15;48(8):1705-10
references.pmid: 7284971
references.citation: Pancreas. 2005 Jul;31(1):88-92
references.pmid: 15968254
references.citation: Semin Oncol. 2001 Jun;28(3 Suppl 10):25-33
references.pmid: 11510031
references.citation: Can J Gastroenterol. 2002 Feb;16(2):101-5
references.pmid: 11875594
references.citation: Surgery. 1995 Jun;117(6):616-23
references.pmid: 7778025
references.citation: Oncology (Williston Park). 2003 Dec;17(12 Suppl 13):29-36
references.pmid: 14723004
references.citation: Arch Surg. 1985 Aug;120(8):899-903
references.pmid: 4015380
references.citation: Pancreas. 2006 Oct;33(3):240-5
references.pmid: 17003644
references.citation: Ann Surg. 1998 Oct;228(4):508-17
references.pmid: 9790340
references.citation: World J Surg. 2000 Sep;24(9):1121-9
references.pmid: 11036292
references.citation: Arch Surg. 2003 Dec;138(12):1316-22
references.pmid: 14662531
references.citation: Surgery. 2005 Jun;137(6):606-11
references.pmid: 15933626
references.citation: Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):353-9
references.pmid: 7836089
references.citation: Ann Surg. 1995 Jan;221(1):59-66
references.pmid: 7826162
references.citation: Cancer. 1990 Jul 1;66(1):56-61
references.pmid: 2354408
references.citation: Surgery. 1997 Mar;121(3):244-9
references.pmid: 9068665
references.citation: Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4
references.pmid: 10615932
references.citation: Ann Surg. 1986 Jul;204(1):65-71
references.pmid: 3015059
references.citation: Med Phys. 2007 Feb;34(2):521-9
references.pmid: 17388169
references.citation: Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1236-44
references.pmid: 15234061
references.citation: Pancreas. 2004 Apr;28(3):219-30
references.pmid: 15084961
references.citation: Ann Surg. 1999 May;229(5):613-22; discussion 622-4
references.pmid: 10235519
references.citation: Rays. 2000 Oct-Dec;25(4):463-84
references.pmid: 11367914
references.citation: Am J Surg. 2004 Jun;187(6):736-40
references.pmid: 15191867
references.citation: Mol Imaging Biol. 2010 Aug;12(4):452-9
references.pmid: 19949988
references.citation: Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):454-9
references.pmid: 15145162
references.citation: Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):274-83
references.pmid: 16618582
references.citation: Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):144-53
references.pmid: 12504047
references.citation: J Natl Cancer Inst. 1988 Jul 20;80(10):751-5
references.pmid: 2898536
references.citation: Gastrointest Cancer Res. 2009 Jan;3(1):20-8
references.pmid: 19343134
references.citation: J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79
references.pmid: 11307091
references.citation: Cancer. 1999 Feb 1;85(3):583-90
references.pmid: 10091731
references.citation: Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1021-9
references.pmid: 15990004
references.citation: Cancer. 1992 Oct 15;70(8):2061-6
references.pmid: 1327485
references.citation: Cancer. 1989 Sep 1;64(5):1132-7
references.pmid: 2547508
references.citation: J Clin Oncol. 1997 Jun;15(6):2403-13
references.pmid: 9196156
references.citation: Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1468-74
references.pmid: 19464822
references.citation: J Clin Oncol. 1998 Jan;16(1):317-23
references.pmid: 9440759
references.citation: Int J Pancreatol. 1993 Feb;13(1):15-22
references.pmid: 8454914
references.citation: J Nucl Med. 2008 Sep;49(9):1408-13
references.pmid: 18703604
references.citation: World J Gastroenterol. 2003 Nov;9(11):2561-4
references.pmid: 14606097
references.citation: J Nucl Med. 2004 Aug;45(8):1279-86
references.pmid: 15299049